Results 271 to 280 of about 2,397,304 (343)

[⁸⁹Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors. [PDF]

EJNMMI Radiopharm Chem
Sanwick AM, Haugh KN, Williams EJ, Perry KA, Thiele NA, Chaple IF.   +5 more
europepmc   +1 more source

Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly.

Journal of Clinical Endocrinology and Metabolism, 2013
F. Gatto, R. Feelders, R. van der Pas, J. Kros, M. Waaijers, D. Sprij-Mooij, S. Neggers, A. van der Lelij, F. Minuto, S. Lamberts, W. D. de Herder, D. Ferone, L. Hofland   +12 more
semanticscholar   +1 more source

Appropriate use of tissue sampling and somatostatin receptor PET imaging in the diagnosis of pancreatic neuroendocrine tumors: results of an International Delphi Consensus. [PDF]

Surg Endosc
Casey M, Tozzi F, Wang J, Park KM, Bergsland E, Hope T, Kennecke HF, Rose JB, Babicky M, Irani SS, El-Hayek KM, Hilal MA, Asbun HJ, Cleary S, Smeets P, Berrevoet F, Adam M, Rashidian N, Alseidi A, PNET Diagnosis Research Group.   +19 more
europepmc   +1 more source

Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.

Journal of Clinical Endocrinology and Metabolism, 2012
C. Bruin, L. Hofland, L. Nieman, P. Koetsveld, A. M. Waaijers, D. Sprij-Mooij, M. Essen, S. Lamberts, W. Herder, R. Feelders   +9 more
semanticscholar   +1 more source

Quality of life as a predictor for survival in patients with small intestinal neuroendocrine tumours

Journal of Neuroendocrinology, Volume 37, Issue 11, November 2025.
Abstract Health‐related quality of life (HRQoL) has been shown to predict overall survival (OS) in several different malignancies, but not in patients with small intestinal neuroendocrine tumours (siNET). We evaluated the influence of HRQoL on survival in patients with siNET. We included 85 patients with advanced siNET who completed the validated HRQoL
Håkan Ohlsson, Martin Nilsson, Anna Sundlöv, Marlene Malmström, Martin Almquist   +4 more
wiley   +1 more source

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. [PDF]

Br J Clin Pharmacol
Luo R, Madan A, Ferrara-Cook CT, Dalvie D, Goulet L, Struthers RS, Krasner AS.   +6 more
europepmc   +1 more source

Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations

Journal of Neuroendocrinology, Volume 37, Issue 11, November 2025.
Gastro‐entero‐pancreatic neuroendocrine neoplasms (GEP‐NENs) exhibit substantial clinical heterogeneity and necessitate a multidisciplinary, personalized approach. Artificial intelligence (AI), through advanced imaging analysis and predictive modeling, offers new opportunities to support diagnosis and guide management.
Elettra Merola, Giuseppe Fanciulli, Giovanni Mario Pes, Maria Pina Dore   +3 more
wiley   +1 more source

Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival. [PDF]

Cancers (Basel)
Perrone E, Calcagni ML, Leccisotti L, Moretti R, Ghai K, Eismant A, Parkar T, Greifenstein L, Baum RP.   +8 more
europepmc   +1 more source

Telotristat ethyl affects tumour‐fibroblast crosstalk in small intestinal neuroendocrine tumours

Journal of Neuroendocrinology, Volume 37, Issue 11, November 2025.
Abstract Small intestinal neuroendocrine tumours (SI‐NETs) are associated with mesenteric fibrosis, which causes significant morbidity and mortality. Telotristat ethyl was developed to treat carcinoid syndrome in SI‐NET patients. Recent studies indicated telotristat ethyl could have anti‐tumour activity; however, the mechanism remains unclear.
Harry Hodgetts, Maria Castanho Martins, Luohai Chen, Andrew R. Hall, Tu Vinh Luong, Dalvinder Mandair, Martyn Caplin, Krista Rombouts   +7 more
wiley   +1 more source

Unveiling Hemangiopericytoma: <i>A case demonstrating the utility of somatostatin receptor-positive metastatic hemangiopericytoma on ⁶⁸Ga-DOTA TOC PET/CT</i>. [PDF]

Sultan Qaboos Univ Med J
Usmani S, Riyami KA, Jain A, Hashmi SF, Abubakar S, Busaidi AA.   +5 more
europepmc   +1 more source